SEARCH RESULTS FOR:
Daniel Bortowski
DIRECTOR, CORE CASE
"A drilling sample can be as valuable as a luxury apartment and can contain invaluable data, yet it is often stored haphazardly."
Ontario’s Critical Minerals
Ontario Mining and Toronto's Global Reach 2024
Connecting the links in Canada’s EV supply chain
Nathalie Tousignant
PRESIDENT, OCTANT AVIATION
"We anticipate significant growth in the airport planning sector, driven by the need for infrastructure to meet the transportation demands of mining companies."
Maïté Blanchette Vézina
MINISTER OF NATURAL RESOURCES AND FORESTS, GOVERNMENT OF QUÉBEC
"On top of the most diverse resource base in Canada, Québec offers visionary and coherent government policies, while partnering in investments to create a favorable business environment for mining."
Francisco Monteiro
CHAIRMAN AND CEO, BRIMONT
"Within a few days, we can transform barren sites into fully equipped facilities, demonstrating our adaptability in supporting Angola's energy sector."
Eugene Ng
GENERAL MANAGER FOR SALES & MARKETING, ASIA PACIFIC REGION, CHEVRON ORONITE
"Successive supply chain shocks and disruptions in recent years forced a sizeable number of our competitors to declare force majeure, leaving Chevron Oronite as the one of the few additive producers continuing operations."
Andreas Kappler
HEAD - VERTICAL MANAGEMENT CHEMICAL & PHARMA ASEAN, SIEMENS
"We follow a clear vision to deploy Siemens Industrial Copilots along the entire value chain, combining mechanistic models, AI techniques like GenAI, and other Advanced Process Control technologies."
Gonzalo Silva
REGIONAL MANAGER – FLOW CONTROL BUSINESS LINE, VALMET
"In Chile, we want to expand the availability of our stock and increase the flexibility in valve assemblies, as well as our service presence."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
